Development of hydrogen sulfide donors for anti-atherosclerosis therapeutics research: Challenges and future priorities

• Ye-Wei Yang,
• Nian-Hua Deng,
• Kai-Jiang Tian,
• Lu-Shan Liu,
• Zuo Wang,
• Dang-Heng Wei,
• Hui-Ting Liu,
• Zhi-Sheng Jiang

Affiliations

Ye-Wei Yang

Hunan Provincial Key Laboratory for Special Pathogens Prevention and Control, Hunan Province Cooperative Innovation Center for Molecular Target New Drug Study, Institute of Pathogenic Biology, Hengyang Medical School, University of South China, Hengyang, China

Nian-Hua Deng

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China

Kai-Jiang Tian

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China

Lu-Shan Liu

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China

Zuo Wang

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China

Dang-Heng Wei

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China

Hui-Ting Liu

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China

Zhi-Sheng Jiang

Key Laboratory for Arteriosclerosis of Hunan Province, Hengyang Medical College, Institute of Cardiovascular Disease, University of South China, Hengyang, China